CVS Health: EPS halved in Q3

(CercleFinance.com) - CVS Health reported adjusted EPS for the third quarter of 2024 more than halved (-51%) to $1.
09, penalized to the tune of 63 cents by charges for premium deficiency reserves in its healthcare benefits segment.

The group explains that these exceptional charges, totaling $1.1 billion, relate to anticipated losses for the last three months of the year, within its Medicare and individual exchange product lines.

CVS Health saw its adjusted operating profit fall by 42.8% to $2.55 billion, on revenues up 6.3% to over $95.4 billion, driven by the healthcare benefits and consumer pharmacy-wellness segments.

Copyright (c) 2024 CercleFinance.com. All rights reserved.